2016 - Commitment To A Cure Award - Cytokinetics, Inc.

On June 3, 2016 Cytokinetics, Inc. received the Golden West Chapter's "Commitment to a Cure" Award for championing ALS drug development, supporting ALS awareness, and enhancing the quality of care for people living with ALS and their families.

2016 - Commitment To A Cure Award - Cytokinetics, Inc.

#IceBucketChallenge -"Behind the Scenes" at the Cytokinetics Challenge event

Honorary Co-Chair Larry Baer, President & CEO San Francisco Giants at Champions for Care and a Cure

50 in 30 Challenge with Cytokinetics

Cytokinetics Drops 20.5% After Presenting ALS Treatment Study Results

News Update: Cytokinetics (NASDAQ:CYTK) Plans To Initiate Phase II Trial For ALS Drug

Cytokinetics’ tribute to advocates at the International Alliance Meeting 2021

Why We Do What We Do

2016 - Spirit Award - Matt Chaney

Cytokinetics Welcome to the 32nd International Symposium on ALS/MND

Donna and Cytokinetics (2012 - 2019)

#ALS #GoldenWest #SFGIANTS @Giants Day at #ATT Park

Cytokinetics #ChallengeMe Event

Video #133 - WHO IS CYTOKINETICS PHARMACEUTICALS And What Do They Do?

Part 1: Mission Driven - Fortitude on the Frontiers of Science

The ALS Ice Bucket Challenge: Figuring out ALS

Cytokinetics Amgen CK-452 inotrope drug candidate

Heart Failure: The Epidemic No One Talks About

Cytokinetics (CYTK) tumbled - should I buy?